8-K
filed May 22, 2025, 7:59 PM ET
ticker SCNX
CIK 0001382574
leadership
confidence high
sentiment neutral
materiality 0.75
Scienture Holdings, Inc. (SCNX): Nasdaq/NYSE listing notice — Scienture Holdings CEO and President resign; Nasdaq bid-price deficiency received
Scienture Holdings, Inc.
- CEO Suren Ajjarapu and Chairman resigned May 16; President Prashant Patel resigned May 20, both no disputes.
- Dr. Narasimhan Mani and Dr. Shankar Hariharan appointed co-CEOs effective May 20; Mani also President and director.
- Terminated purchase agreement with Arena Business Solutions Global SPC II effective May 22, no penalties.
- Nasdaq notice May 19: bid price below $1 for 30 days; 180 days until Nov 17, 2025 to regain compliance.
Key facts
Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Deficiency
- minimum bid price
- Rules
- 5450(a)(1)
Exact text from the filing
May 19, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common stock, par value $0.0001 (“Common Stock”) had been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). According to that notice, the Company has 180 calendar days, or until November 17, 2025, to regain compliance with the Minimum Bid Price Requirement. To
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Suren Ajjarapu resigned as Chief Executive Officer and Chairman of the Board at Scienture Holdings, Inc..
- Action
- resigned
- Role
- Chief Executive Officer and Chairman of the Board
Exact text from the filing
On May 16, 2025, as part of a planned leadership succession, Suren Ajjarapu advised the Company that he was resigning from his position as the Company’s Chief Executive Officer and Chairman of the Board effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Dr. Narasimhan Mani was appointed as co-Chief Executive Officer, President and Director at Scienture Holdings, Inc..
- Action
- appointed
- Role
- co-Chief Executive Officer, President and Director
Exact text from the filing
the Company’s board of directors appointed Dr. Narasimhan Mani, age 50, and Dr. Shankar Hariharan, age 68, to serve as co-Chief Executive Officers of the Company effective as of May 20, 2025.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Prashant Patel resigned as President and Chief Operating Officer at Scienture Holdings, Inc..
- Action
- resigned
- Role
- President and Chief Operating Officer
Exact text from the filing
As part of the planned leadership transition, Prashant Patel also advised the Company that he was resigning from his position as the Company’s President and Chief Operating Officer, effective as of May 20, 2025.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Dr. Shankar Hariharan was appointed as Executive Chairman and co-Chief Executive Officer at Scienture Holdings, Inc..
- Action
- appointed
- Role
- Executive Chairman and co-Chief Executive Officer
Exact text from the filing
The board of directors also appointed Dr. Mani to serve as a director on the Company’s board of directors to fill the vacancy created as a result of Mr. Ajjarapu’s resignation and appointed Dr. Hariharan to the position of Executive Chairman of the Company’s board of directors, each effective as of May 20, 2025.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.